The U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases.
Nov 3, 2023
0
1
The U.S. Food and Drug Administration (FDA) approved mirikizumab, on October 26, 2023, a highly effective new treatment for ulcerative colitis (UC), offering a new option to patients battling this chronic and debilitating ...
Oct 30, 2023
0
0
Inflammatory bowel diseases (IBDs), such as Crohn's disease or ulcerative colitis, arise when there is a dysregulation of the cell signaling pathways controlling the maintenance of homeostasis in the gut, leading to a chronic ...
Oct 26, 2023
0
0
The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high radiation doses following nuclear incidents develop radiation-induced lung injury (RILI), which affects the function of ...
Oct 17, 2023
0
22
Inflammatory breast cancer is rare, but it's aggressive, fast-growing and hard to detect early, so it's important to know the warning signs.
Oct 16, 2023
0
1
Some common medications—including antidepressants, sleep aids and painkillers—may dull the driving skills of seniors, a new study finds.
Oct 3, 2023
0
80
Millions of Americans suffer from arthritis, and many reach for medication to ease their joint pain and inflammation.
Sep 19, 2023
0
1
A preclinical study led by Monash University has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer called hepatocellular carcinoma ...
Sep 14, 2023
0
34
The US Federal Trade Commission (FTC) announced an agreement on Friday allowing American drug manufacturer Amgen to proceed with its $28 billion takeover of Horizon Therapeutics.
Sep 1, 2023
0
4
Acetaminophen or non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen are recommended as first-line treatments for managing short-term dental pain in children under age 12, according to a new clinical practice guideline ...
Aug 25, 2023
0
2
